33 min listen
IVIg to Treat Severe Refractory HIT
ratings:
Length:
38 minutes
Released:
Nov 22, 2017
Format:
Podcast episode
Description
Anand Padmanabhan, MD, PhD, and editorialist Theodore Warkentin, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the paper by Padamanabhan et al, which describes outcomes in three patients with heparin-induced thrombocytopenia (HIT) who responded well to IVIg therapy.
Released:
Nov 22, 2017
Format:
Podcast episode
Titles in the series (100)
Modifying Criteria For Systemic Inflammatory Response Syndrome To Improve Its Predictive Value: Simon J. Finney, PhD, MBChB, editiorialist Arthur P. Wheeler, MD, FCCP, and CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, discuss an article by Dr. Finney and others that reviews their research into modifying the traditional definition of the systemic... by CHEST Journal Podcasts